R. Andrew Ramelmeier

2021

In 2021, R. Andrew Ramelmeier earned a total compensation of $1.7M as Executive Vice President, Technical Operations at Sangamo Biosciences, a 10% increase compared to previous year.

Compensation breakdown

Bonus$50,000
Non-Equity Incentive Plan$179,712
Option Awards$591,728
Salary$416,000
Stock Awards$447,600
Other$5,554
Total$1,690,594

Ramelmeier received $591.7K in option awards, accounting for 35% of the total pay in 2021.

Ramelmeier also received $50K in bonus, $179.7K in non-equity incentive plan, $416K in salary, $447.6K in stock awards and $5.6K in other compensation.

Rankings

In 2021, R. Andrew Ramelmeier's compensation ranked 6,735th out of 12,415 executives tracked by ExecPay. In other words, Ramelmeier earned more than 45.8% of executives.

ClassificationRankingPercentile
All
6,735
out of 12,415
46th
Division
Manufacturing
2,922
out of 5,505
47th
Major group
Chemicals And Allied Products
1,288
out of 2,375
46th
Industry group
Drugs
1,147
out of 2,096
45th
Industry
Biological Products, Except Diagnostic Substances
271
out of 449
40th

Pay ratio

R. Andrew Ramelmeier's Pay$1,690,594
Median Employee's Pay$170,218
Pay Ratio

10

to 1

In 2021, the annual total compensation of R. Andrew Ramelmeier was $1,690,594.

The annual total compensation of the median employee at Sangamo Biosciences was $170,218.

The ratio of R. Andrew Ramelmeier's pay to the pay of median employee was therefore 10 to one.

Source: SEC filing on April 1, 2022.

Ramelmeier's colleagues

We found five more compensation records of executives who worked with R. Andrew Ramelmeier at Sangamo Biosciences in 2021.

2021

Alexander Macrae

Sangamo Biosciences

Chief Executive Officer

2021

Robert Schott

Sangamo Biosciences

Senior Vice President, Head of Development

2021

D McClung

Sangamo Biosciences

Chief Operating Officer

2021

Prathyusha Duraibabu

Sangamo Biosciences

Chief Financial Officer

2021

Sung Lee

Sangamo Biosciences

Chief Financial Officer

News

You may also like